美股新聞 標題聯播 · 近 24 小時 305 則 · 28 個來源 · 最新 9/20 06:00
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · LQDA近 30 天 8 則 · 第 1 / 1 頁
- LQDA Loses 13.9% in a Month: Should Investors Avoid the Stock Now?
- Can a Potential Label Expansion of Yutrepia Boost LQDA's Portfolio?
- Liquidia (LQDA) Stock Looks Stretched On Earnings But Reasonable On Broader Checks
- Liquidia Corporation’s (LQDA) Yutrepia Launch Continues to Outpace the Expectations
- Liquidia to Present Posters at the European Respiratory Society (ERS) 2026 Congress
- Can LQDA's Yutrepia Sustain Growth Amid Fierce PAH Competition?
- Is the Options Market Predicting a Spike in Liquidia Stock?
- Will LQDA's Differentiated PAH Approach Drive Growth?
- Can Yutrepia's Strong Growth Drive Liquidia's PAH Expansion?
- LQDA Stock Down Post Q2 Earnings Release: What Should Investors Do Now?
- Greenhaven Road Capital: Short Term Gain Realized from Liquidia (LQDA), Investment to Be Revisited
- Liquidia Corporation (LQDA) Q2 Earnings and Revenues Beat Estimates
- Interstitial Lung Disease Market to Witness Accelerated Growth at a CAGR of 8.7% During the Forecast Period (2026–2036) Due to the Launch of Emerging Therapies | DelveInsight
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。